mTOR Signaling and SREBP Activity Increase FADS2 Expression and Can Activate Sapienate Biosynthesis.
Cell Reports
Triki, Mouna M; Rinaldi, Gianmarco G; Planque, Melanie M; Broekaert, Dorien D; Winkelkotte, Alina M AM; Maier, Carina R CR; Janaki Raman, Sudha S; Vandekeere, Anke A; Van Elsen, Joke J; Orth, Martin F MF; Grünewald, Thomas G P TGP; Schulze, Almut A; Fendt, Sarah-Maria SM
NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesis.
Oncogene
Luiken, Sarah S; Fraas, Angelika A; Bieg, Matthias M; Sugiyanto, Raisatun R; Goeppert, Benjamin B; Singer, Stephan S; Ploeger, Carolin C; Warsow, Gregor G; Marquardt, Jens U JU; Sticht, Carsten C; De La Torre, Carolina C; Pusch, Stefan S; Mehrabi, Arianeb A; Gretz, Norbert N; Schlesner, Matthias M; Eils, Roland R; Schirmacher, Peter P; Longerich, Thomas T; Roessler, Stephanie S
Publication Date: 2020-04
Variant appearance in text: TSC2: 2380C>T; Q794*; rs45517233
Dissecting the genetic basis of focal cortical dysplasia: a large cohort study.
Acta Neuropathologica
Baldassari, Sara S; Ribierre, Théo T; Marsan, Elise E; Adle-Biassette, Homa H; Ferrand-Sorbets, Sarah S; Bulteau, Christine C; Dorison, Nathalie N; Fohlen, Martine M; Polivka, Marc M; Weckhuysen, Sarah S; Dorfmüller, Georg G; Chipaux, Mathilde M; Baulac, Stéphanie S
Publication Date: 2019-12
Variant appearance in text: TSC2: 2380C>T; Gln794*
Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets.
Nature Communications
Chen, Ying-Bei YB; Xu, Jianing J; Skanderup, Anders Jacobsen AJ; Dong, Yiyu Y; Brannon, A Rose AR; Wang, Lu L; Won, Helen H HH; Wang, Patricia I PI; Nanjangud, Gouri J GJ; Jungbluth, Achim A AA; Li, Wei W; Ojeda, Virginia V; Hakimi, A Ari AA; Voss, Martin H MH; Schultz, Nikolaus N; Motzer, Robert J RJ; Russo, Paul P; Cheng, Emily H EH; Giancotti, Filippo G FG; Lee, William W; Berger, Michael F MF; Tickoo, Satish K SK; Reuter, Victor E VE; Hsieh, James J JJ
Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Voss, Martin H MH; Hakimi, A Ari AA; Pham, Can G CG; Brannon, A Rose AR; Chen, Ying-Bei YB; Cunha, Luis F LF; Akin, Oguz O; Liu, Han H; Takeda, Shugaku S; Scott, Sasinya N SN; Socci, Nicholas D ND; Viale, Agnes A; Schultz, Nikolaus N; Sander, Chris C; Reuter, Victor E VE; Russo, Paul P; Cheng, Emily H EH; Motzer, Robert J RJ; Berger, Michael F MF; Hsieh, James J JJ